MYNX Venous VCD

Device CORDIS US CORP.
Total Payments
$2.3M
Transactions
80
Doctors
4
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $30,593 12 4
2023 $2.3M 68 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $2.3M 80 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
A MULTICENTER, PROSPECTIVE, RANDOMIZED, CONTROLLED, OPEN LABEL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF MYNX CONTROL VENOUS VASCULAR CLOSURE DEVICE 6F-12F VS. MANUAL COMPRESSION IN PATIENTS WHO HAVE UNDERGONE ENDOVASCULAR PROCEDURES UTILIZING UP TO 12F PROCEDURAL SHEATHS CORDIS US CORP. $2.3M 4

Top Doctors Receiving Payments for MYNX Venous VCD

Doctor Specialty Location Total Records
Unknown Raleigh, NC $2.3M 76
, M.D Cardiovascular Disease Oklahoma City, OK $1,450 1
, MD Clinical Cardiac Electrophysiology Lakewood, CO $1,450 1
, M.D Clinical Cardiac Electrophysiology Phoenix, AZ $1,450 1
, MD, FACC, FSCAI Cardiovascular Disease Mckinney, TX $1,450 1

About MYNX Venous VCD

MYNX Venous VCD is a device associated with $2.3M in payments to 4 healthcare providers, recorded across 80 transactions in the CMS Open Payments database. The primary manufacturer is CORDIS US CORP..

Payment data is available from 2023 to 2024. In 2024, $30,593 was paid across 12 transactions to 4 doctors.

The most common payment nature for MYNX Venous VCD is "Unspecified" ($2.3M, 100.0% of total).

MYNX Venous VCD is associated with 1 research study, including "A MULTICENTER, PROSPECTIVE, RANDOMIZED, CONTROLLED, OPEN LABEL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF MYNX CONTROL VENOUS VASCULAR CLOSURE DEVICE 6F-12F VS. MANUAL COMPRESSION IN PATIENTS WHO HAVE UNDERGONE ENDOVASCULAR PROCEDURES UTILIZING UP TO 12F PROCEDURAL SHEATHS" ($2.3M).